These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37743129)

  • 21. Comparing Cardiac Magnetic Resonance-Guided Versus Angiography-Guided Treatment of Patients With Stable Coronary Artery Disease: Results From a Prospective Randomized Controlled Trial.
    Buckert D; Witzel S; Steinacker JM; Rottbauer W; Bernhardt P
    JACC Cardiovasc Imaging; 2018 Jul; 11(7):987-996. PubMed ID: 29976305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of computed tomography myocardial perfusion imaging in clinical practice.
    Singh A; Mor-Avi V; Patel AR
    J Cardiovasc Comput Tomogr; 2020; 14(2):185-194. PubMed ID: 31227445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocardial Ischemia in the Management of Chronic Coronary Artery Disease: Past and Present.
    Gibbons RJ
    Circ Cardiovasc Imaging; 2021 Jan; 14(1):e011615. PubMed ID: 33455408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Percutaneous coronary intervention versus bypass surgery in patients with diabetes and multivessel coronary disease. Coronary revascularization after FREEDOM].
    Dörr R; Stumpf J; Dalibor J; Simonis G; Spitzer SG
    Herz; 2014 May; 39(3):331-42. PubMed ID: 24740094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CT-based myocardial ischemia evaluation: quantitative angiography, transluminal attenuation gradient, myocardial perfusion, and CT-derived fractional flow reserve.
    Koo HJ; Yang DH; Kim YH; Kang JW; Kang SJ; Kweon J; Kim HJ; Lim TH
    Int J Cardiovasc Imaging; 2016 Jun; 32 Suppl 1():1-19. PubMed ID: 26667445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation).
    Zhang Z; Jones P; Weintraub WS; Mancini GBJ; Sedlis S; Maron DJ; Teo K; Hartigan P; Kostuk W; Berman D; Boden WE; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e003971. PubMed ID: 29752388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design.
    ; Maron DJ; Hochman JS; O'Brien SM; Reynolds HR; Boden WE; Stone GW; Bangalore S; Spertus JA; Mark DB; Alexander KP; Shaw L; Berger JS; Ferguson TB; Williams DO; Harrington RA; Rosenberg Y
    Am Heart J; 2018 Jul; 201():124-135. PubMed ID: 29778671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps).
    Nørgaard BL; Leipsic J; Gaur S; Seneviratne S; Ko BS; Ito H; Jensen JM; Mauri L; De Bruyne B; Bezerra H; Osawa K; Marwan M; Naber C; Erglis A; Park SJ; Christiansen EH; Kaltoft A; Lassen JF; Bøtker HE; Achenbach S;
    J Am Coll Cardiol; 2014 Apr; 63(12):1145-1155. PubMed ID: 24486266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis and management of silent coronary ischemia in patients undergoing carotid endarterectomy.
    Krievins D; Zellans E; Latkovskis G; Jegere S; Kumsars I; Kaufmanis K; Erglis A; Zarins CK
    J Vasc Surg; 2021 Feb; 73(2):533-541. PubMed ID: 32623107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Implications of the ISCHEMIA Trial: Invasive vs Conservative Approach in Stable Coronary Disease.
    Choudhary J; Chiu S; Bhugra P; Bikdeli B; Supariwala A; Jauhar R; Chatterjee S
    Curr Cardiol Rep; 2021 Mar; 23(5):43. PubMed ID: 33704597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anatomic or functional testing in stable patients with suspected CAD: contemporary role of cardiac CT in the ISCHEMIA trial era.
    Rodriguez-Granillo GA; Nieman K; Carrascosa P; Campisi R; Ambrose JA
    Int J Cardiovasc Imaging; 2020 Jul; 36(7):1351-1362. PubMed ID: 32180079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lesion-Specific and Vessel-Related Determinants of Fractional Flow Reserve Beyond Coronary Artery Stenosis.
    Ahmadi A; Leipsic J; Øvrehus KA; Gaur S; Bagiella E; Ko B; Dey D; LaRocca G; Jensen JM; Bøtker HE; Achenbach S; De Bruyne B; Nørgaard BL; Narula J
    JACC Cardiovasc Imaging; 2018 Apr; 11(4):521-530. PubMed ID: 29311033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rationale, design and goals of the HeartFlow assessing diagnostic value of non-invasive FFR
    Chinnaiyan KM; Akasaka T; Amano T; Bax JJ; Blanke P; De Bruyne B; Kawasaki T; Leipsic J; Matsuo H; Morino Y; Nieman K; Norgaard BL; Patel MR; Pontone G; Rabbat M; Rogers C; Sand NP; Raff G
    J Cardiovasc Comput Tomogr; 2017; 11(1):62-67. PubMed ID: 28017291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-invasive fractional flow reserve derived from coronary computed tomography angiography in patients with acute chest pain: Subgroup analysis of the ROMICAT II trial.
    Ferencik M; Lu MT; Mayrhofer T; Puchner SB; Liu T; Maurovich-Horvat P; Ghemigian K; Ivanov A; Adami E; Nagurney JT; Woodard PK; Truong QA; Udelson JE; Hoffmann U
    J Cardiovasc Comput Tomogr; 2019; 13(4):196-202. PubMed ID: 31113728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Routine Fractional Flow Reserve on Management Decision and 1-Year Clinical Outcome of Patients With Acute Coronary Syndromes: PRIME-FFR (Insights From the POST-IT [Portuguese Study on the Evaluation of FFR-Guided Treatment of Coronary Disease] and R3F [French FFR Registry] Integrated Multicenter Registries - Implementation of FFR [Fractional Flow Reserve] in Routine Practice).
    Van Belle E; Baptista SB; Raposo L; Henderson J; Rioufol G; Santos L; Pouillot C; Ramos R; Cuisset T; Calé R; Teiger E; Jorge E; Belle L; Machado C; Barreau D; Costa M; Hanssen M; Oliveira E; Besnard C; Costa J; Dallongeville J; Pipa J; Sideris G; Fonseca N; Bretelle C; Guardado J; Lhoest N; Silva B; Barnay P; Sousa MJ; Leborgne L; Silva JC; Vincent F; Rodrigues A; Seca L; Fernandes R; Dupouy P;
    Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28615234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of association between epicardial fat volume and extent of coronary artery calcification, severity of coronary artery disease, or presence of myocardial perfusion abnormalities in a diverse, symptomatic patient population: results from the CORE320 multicenter study.
    Tanami Y; Jinzaki M; Kishi S; Matheson M; Vavere AL; Rochitte CE; Dewey M; Chen MY; Clouse ME; Cox C; Kuribayashi S; Lima JA; Arbab-Zadeh A
    Circ Cardiovasc Imaging; 2015 Mar; 8(3):e002676. PubMed ID: 25752899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical application of results of the ISCHEMIA trial.
    Kanoun Schnur SS; Achim A; Toth GG
    Trends Cardiovasc Med; 2023 Feb; 33(2):125-130. PubMed ID: 34737088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. After ISCHEMIA: Is cardiac MRI a reliable gatekeeper for invasive angiography and myocardial revascularization?
    Nagel E; Carerj ML; Arendt CT; Puntmann VO
    Herz; 2020 Aug; 45(5):446-452. PubMed ID: 32458013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Single-Vessel Coronary Artery Disease.
    Al-Lamee R; Howard JP; Shun-Shin MJ; Thompson D; Dehbi HM; Sen S; Nijjer S; Petraco R; Davies J; Keeble T; Tang K; Malik IS; Cook C; Ahmad Y; Sharp ASP; Gerber R; Baker C; Kaprielian R; Talwar S; Assomull R; Cole G; Keenan NG; Kanaganayagam G; Sehmi J; Wensel R; Harrell FE; Mayet J; Thom SA; Davies JE; Francis DP
    Circulation; 2018 Oct; 138(17):1780-1792. PubMed ID: 29789302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. After ISCHEMIA: is invasive physiology the only remaining gatekeeper for myocardial revascularization in chronic coronary syndromes?
    Kanoun S; Toth GG
    Herz; 2020 Aug; 45(5):453-457. PubMed ID: 32494947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.